Liquid Gentamicin and Vancomycin in Bone Cement. A Potentially More Cost-Effective Regimen

Journal of Arthroplasty

Volumn 24, Issue 1, 2009, Pages 125-130

  Hsieh, Pang Hsin ^a   Tai, Ching Lung ^a,b   Lee, Po Chen ^a   Chang, Yu Han ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

antibiotic elution; bone cement; gentamicin; vancomycin

Indexed keywords

GENTAMICIN; GENTAMICIN BONE CEMENT; VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; BIOASSAY; BONE INFECTION; COMPRESSIVE STRENGTH; COST EFFECTIVENESS ANALYSIS; DRUG ACTIVITY; DRUG FORMULATION; ELUTION; HUMAN; HUMAN TISSUE; LIQUID; MYOSITIS; POROSITY; POWDER; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY; BONE CEMENTS; COST-BENEFIT ANALYSIS; DRUG DELIVERY SYSTEMS; GENTAMICINS; HUMANS; MATERIALS TESTING; POLYMETHYL METHACRYLATE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VANCOMYCIN;

EID: 57649085205     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2008.01.131     Document Type: Article

References (16)

1. Hsieh P.H., Chang Y.H., Chen S.H., et al. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res 24 (2006) 1615
2. Hsieh P.H., Shih C.H., Chang Y.H., et al. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg 86A (2004) 1989
3. Neut D., Hendriks J.G., van Horn J.R., et al. Antimicrobial efficacy of gentamicin-loaded acrylic bone cements with fusidic acid or clindamycin added. J Orthop Res 24 (2006) 291
4. Bernard L., Vaudaux P., Vuagnat A., et al., Osteomyelitis Study Group. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance. Infect Control Hosp Epidemiol 24 (2003) 650
5. Bertazzoni Minelli E., Benini A., Magnan B., et al. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 53 (2004) 329
6. Lautenschlager E.P., Marshall G.W., Marks K.E., et al. Mechanical strength of acrylic bone cements impregnated with antibiotics. J Biomed Mater Res 10 (1976) 837
7. Seldes R.M., Winiarsky R., Jordan L.C., et al. Liquid gentamicin in bone cement: a laboratory study of a potentially more cost-effective cement spacer. J Bone Joint Surg 87A (2005) 268
8. Klekamp J., Dawson J.M., Hass D.W., et al. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 14 (1999) 339
9. Jiranek W.A., Hanssen A.D., and Greenwald A.S. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg 88A (2006) 2487
10. Neut D., van de Belt H., van Horn J.R., et al. The effect of mixing on gentamicin release from polymethylmethacrylate bone cements. Acta Orthop Scand 74 (2003) 670
11. Penner M.J., Masri B.A., and Duncan C.P. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 11 (1996) 939
12. Kuechle D.K., Landon G.C., Musher D.M., et al. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res 264 (1991) 302
13. McLaren A.C., McLaren S.G., and Smeltzer M. Xylitol and glycine fillers increase permeability of PMMA to enhance elution of daptomycin. Clin Orthop Relat Res 451 (2006) 25
14. Hovelius L., and Josefsson G. An alternative method for exchange operation of infected arthroplasty. Acta Orthop Scand 50 (1979) 93
15. Lam K., and Bayer A.S. In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci. Antimicrob Agents Chemother 26 (1984) 260
16. Anguita-Alonso P., Hanssen A.D., Osmon D.R., et al. High rate of aminoglycoside resistance among staphylococci causing prosthetic joint infection. Clin Orthop Relat Res 439 (2005) 43